Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage

Colloids and Surfaces B: Biointerfaces

Volumn 129, Issue , 2015, Pages 21-29

  Yang, Lijun ^a   Wang, Feng ^a   Han, Haie ^a   Yang, Liang ^a   Zhang, Gengshen ^a   Fan, Zhenzeng ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Drug delivery; Graphene; Pirfenidone; Subarachnoid hemorrhage

Indexed keywords

BLOOD; CARDIOVASCULAR SYSTEM; DRUG DELIVERY; GRAPHENE; INFRARED DEVICES; MOTION PICTURE EXPERTS GROUP STANDARDS; NANOSHEETS; TISSUE; WATER CONTENT;

CENTRAL NERVOUS SYSTEM INJURIES; FUNCTIONALIZED GRAPHENE; GRAPHENE OXIDE NANOSHEETS; METHOXYPOLYETHYLENE GLYCOL; PHOTO-ACOUSTIC IMAGING; PIRFENIDONE; SUBARACHNOID HEMORRHAGES; TRANSCRIPTION ACTIVATORS;

LOADING;

DRUG CARRIER; GRAPHENE OXIDE; MACROGOL; PIRFENIDONE; TRANSACTIVATOR PROTEIN; GRAPHITE; OXIDE; PYRIDONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN SLICE; BRAIN WATER; CIRCULATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG PENETRATION; DRUG STABILITY; IMMUNOHISTOCHEMISTRY; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PH; PHOTOACOUSTICS; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; ANIMAL; BRAIN; CELL SURVIVAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PC12 CELL LINE; TREATMENT OUTCOME;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; GRAPHITE; MICE; OXIDES; PC12 CELLS; PYRIDONES; RATS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84925384747     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.03.022     Document Type: Article

References (35)

1. Schievink W.I., Riedinger M., Jhutty T.K., Simon P. Racial disparities in subarachnoid hemorrhage mortality: Los Angeles County, California, 1985-1998. Neuroepidemiology 2004, 23:299-305.
2. Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994, 25:1342-1347.
3. Hijdra A., van Gijn J., Nagelkerke N.J., Vermeulen M., van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 1988, 19:1250-1256.
4. van Gijn J., Rinkel G.J. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001, 124:249-278.
5. Allen G.S., Ahn H.S., Preziosi T.J., Battye R., Boone S.C., Boone S.C., Chou S.N., Kelly D.L., Weir B.K., Crabbe R.A., Lavik P.J., Rosenbloom S.B., Dorsey F.C., Ingram C.R., Mellits D.E., Bertsch L.A., Boisvert D.P., Hundley M.B., Johnson R.K., Strom J.A., Transou C.R. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N. Engl. J. Med. 1983, 308:619-624.
6. Burger K.N., Staffhorst R.W., de Vijlder H.C., Velinova M.J., Bomans P.H., Frederik P.M., de Kruijff B. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nat. Med. 2002, 8:81-84.
7. Reddy M.K., Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 2009, 23:1384-1395.
8. Tian X.H., Wang Z.G., Meng H., Wang Y.H., Feng W., Wei F., Huang Z.C., Lin X.N., Ren L. Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm. Int. J. Nanomed. 2013, 8:865-876.
9. 3 particles and the application as anticancer drug carrier. J. Am. Chem. Soc. 2008, 130:15808-15810.
10. Yokoyama M., Fukushima S., Uehara R., Okamoto K., Sakurai Y., Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J. Control. Release 1998, 50:79-92.
11. Yang X., Zhang X., Liu Z., Ma Y., Huang Y., Chen Y. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J. Phys. Chem. C 2008, 112:17554-17558.
12. Zhang S., Yang K., Feng L., Liu Z. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon 2011, 49:4040-4049.
13. Sun X., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., Dai H. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008, 1:203-212.
14. Zhang Q., Xu J., Song Q., Li N., Zhang Z., Li K., Du Y., Wu L., Tang M., Liu L., Cheng G., Liu J. Synthesis of amphiphilic reduced graphene oxide with enhanced charge injection capacity for electrical stimulation of neural cells. J. Mater. Chem. B 2014, 2:4331-4337.
15. Patel M.A., Yang H., Chiu P.L., Mastrogiovanni D.D., Flach C.R., Savaram K., Gomez L., Hemnarine A., Mendelsohn R., Garfunkel E., Jiang H., He H. Direct production of graphene nanosheets for near infrared photoacoustic imaging. ACS Nano 2013, 7:8147-8157.
16. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., Li C., Li Y., Liu Z. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv. Mater. 2012, 24:1868-1872.
17. Stankovich S., Dikin D.A., Piner R.D., Kohlhaas K.A., Kleinhammes A., Jia Y., Wu Y., Nguyen S.T., Ruoff R.S. Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 2007, 45:1558-1565.
18. Hummers W.S., Offeman R.E. Preparation of graphitic oxide. J. Am. Chem. Soc. 1958, 80. 1339-1339.
19. Zhang Y., Ali S.F., Dervishi E., Xu Y., Li Z., Casciano D., Biris A.S. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 2010, 4:3181-3186.
20. Park S., Yamaguchi M., Zhou C., Calvert J., Tang J., Zhang J.H. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004, 35:2412-2417.
21. D'Abbondanza J., Lass E., Ai J., Macdonald R.L. Mouse genetic background is associated with variation in secondary complications after subarachnoid hemorrhage. Neurovascular Events After Subarachnoid Hemorrhage 2015, vol. 120:29-33. Springer International Publishing.
22. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1:50-56.
23. Becerril H.A., Mao J., Liu Z., Stoltenberg R.M., Bao Z., Chen Y. Evaluation of solution-processed reduced graphene oxide films as transparent conductors. ACS Nano 2008, 2:463-470.
24. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
25. Moon I.K., Lee J., Ruoff R.S., Lee H. Reduced graphene oxide by chemical graphitization. Nat. Commun. 2010, 1:73.
26. Li D., Muller M.B., Gilje S., Kaner R.B., Wallace G.G. Processable aqueous dispersions of graphene nanosheets. Nat. Nanotechnol. 2008, 3:101-105.
27. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 2008, 130:10876-10877.
28. Zhang L., Xia J., Zhao Q., Liu L., Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6:537-544.
29. Lardner A. The effects of extracellular pH on immune function. J. Leukoc. Biol. 2001, 69:522-530.
30. Hoffman W.E., Wheeler P., Edelman G., Charbel F.T., Torres N.J., Ausman J.I. Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology 2000, 92:442.
31. Wheeler P., Edelman G., Hoffman W.E. Brain tissue metabolites in subarachnoid hemorrhage. Anesth. Analg. 1999, 88:246S.
32. Yang K., Wan J., Zhang S., Zhang Y., Lee S.-T., Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2010, 5:516-522.
33. Fan Q., Cheng K., Yang Z., Zhang R., Yang M., Hu X., Ma X., Bu L., Lu X., Xiong X., Huang W., Zhao H., Cheng Z. Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice. Adv. Mater. 2014, 10.1002/adma.201402972.
34. Smith W.S., Dowd C.F., Johnston S.C., Ko N.U., DeArmond S.J., Dillon W.P., Setty D., Lawton M.T., Young W.L., Higashida R.T. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004, 35:2518-2522.
35. Chiba Y., Sasayama T., Miyake S., Koyama J., Kondoh T., Hosoda K., Kohmura E. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe J. Med. Sci. 2008, 54:E136-E146.